| Cardiovascular Risk Management |
1 |
1 |
| Cardiac Surgery |
0 |
0.87 |
| Lipids Management |
0 |
0.84 |
| Alabama |
0 |
0.48 |
| Congenital Heart Disease |
0 |
0.39 |
| C-Reactive Protein (CRP) |
0 |
0.36 |
| Clinical Guidelines |
0 |
0.36 |
| Aortic Stenosis |
0 |
0.34 |
| Coronary Artery Disease (CAD) |
0 |
0.34 |
| Revenue and Practice Management |
0 |
0.34 |
| Aminotransferase |
0 |
0.33 |
| Cardiovascular disease |
0 |
0.24 |
| Plasma |
0 |
0.24 |
| Stenosis |
0 |
0.24 |
| Acute Respiratory Distress Syndrome |
0 |
0.2 |
| Genomic Medicine |
0 |
0.2 |
| Headache |
0 |
0.2 |
| Vaccines |
0 |
0.2 |
| Apolipoproteins |
0 |
0.12 |
| Artery |
0 |
0.12 |
| Clinical Research |
0 |
0.12 |
| Genetics |
0 |
0.12 |
| Grant |
0 |
0.12 |
| Hospital |
0 |
0.12 |
| Insurance |
0 |
0.12 |
| Interference |
0 |
0.12 |
| LDL Cholesterol |
0 |
0.12 |
| Leukocytosis |
0 |
0.12 |
| Liver |
0 |
0.12 |
| Neutrophils |
0 |
0.12 |
| PCSK9 |
0 |
0.12 |
| Severe Acute Respiratory Syndrome |
0 |
0.12 |
| South Carolina |
0 |
0.12 |